No attachments available.
CFX Opus 96 Real-Time PCR System
Contact and place of performance
Towanda Daniels
CA 94547
USA
COMBINED SYNOPSIS / SOLICITATION WORKFORM (1) Action Code: Combined Synopsis/Solicitation (2) Date: May 12 (3) Year: 2026 (4) Contracting Office Zip Code: 20817 (5) Classification Code: 6640 (6) Contracting Office Address: 6701 Rockledge Drive Bethesda, MD 20817 (7) Subject/Title: CFX Opus 96...
View more(iii) The solicitation document, the incorporated provisions, and clauses are those in effect through Federal Acquisition Circular, FAC Number: 2026-01
Effective Date: 03/13/2026
(iv) This solicitation is being released unrestricted. The NAICS code is 334516, and the small business size standard is 1000 employees. This acquisition is being conducted in accordance with the procedures of FAR Part 12 and FAR Part 13.
(v) The equipment consists of a real-time PCR system capable of supporting multiplex nucleic acid detection and analysis. The system must provide accurate thermal control, reliable fluorescence detection, and compatibility with existing laboratory software and experimental workflows.
The following product features/characteristics are required for this requirement:
System can capture up to five fluorophores in a single reaction well using “All
Channels” scan mode, or, for faster scanning time, one fluorophore when using the SYBRR/FAM or FRET Scan Modes.
Fixed optical path, directly over each well, eliminates the need to normalize for positional bias or passive dye calibration.
System does not have lid or drawer that extends beyond the footprint of the system nor requires additional operating clearance.
Dimensions (W x D x H) is 13x22x14 inches; can easily fit under a standard shelf
Real-time data traces can be viewed during a run from the thermal cycler base or on CFX Maestro (if a computer is connected to the instrument).
CFX Maestro software is compatible with all real time PCR results from the older model CFX system the lab has been using; it shall ensure project continuity.
Multiple plates can be combined into one experiment with the Gene Study Feature on the free CFX Maestro software.
Software performs t-tests and 1-way ANOVA calculations.
The requested system, from Bio-Rad shall provide multiplexing capability, thermal uniformity, and compatibility with existing laboratory workflows and data analysis software to support current and future research requirements.
The provisions at FAR Clause 52.212-1, Instructions to Offerors – Commercial Items, applies to this acquisition. The following addendum related to the Instructions to Offerors is included:
Addendum to FAR Clause 52.212-1, Instructions to Offerors – Commercial Items. Please refer to this addendum for additional attachments, including the Statement of Work and other relevant information.
Evaluations will be conducted in accordance with the provision at FAR Clause 52.212-2. Offerors will be evaluated as follows:
EVALUATION-COMMERCIAL ITEMS (OCT 2014)
(a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers:
• Technical
• Past Performance
• Cost
All evaluation factors other than cost or price, when combined are significantly more important than cost or price.
Written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.
Please refer to the addendum for additional evaluation information.
Each Offeror must include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications – Commercial Items, with its offer.
Please note, each Offeror shall complete only paragraph (b) of this provision if the Offeror has completed the annual representations and certification electronically via the System for Award Management (SAM) website located at
https://www.sam.gov/portal.
FAR Clause 52.212-4, Contract Terms and Conditions – Commercial Items, applies to this acquisition. The terms and conditions outlined in the following addendum also apply:
Addendum to FAR Clause 52.212-4, Contract Terms and Conditions – Commercial Items. Please refer to this addendum for additional terms and conditions related to the requirement.
FAR Clause 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders – Commercial Items, applies to this acquisition. The full text version of FAR 52.212-5 included in the addenda as Attachment 5 indicate which FAR clauses and provisions are applicable to this acquisition.
Contact Information:
Towanda Daniels
Email: [email protected]
(14) Place of Contract Performance: Bethesda, MD
(15) Set-aside Status: N/A
The National Institutes of Health (NIH) is issuing this request for quote (RFQ) under solicitation number 26-003418 to procure a CFX Opus 96 Real-Time PCR System or an equivalent product. This requirement is for a real-time PCR system capable of supporting multiplex nucleic acid detection and analysis through accurate thermal control and reliable fluorescence detection. The system must capture up to five fluorophores in a single reaction well and feature a fixed optical path to eliminate positional bias. For laboratory space efficiency, the unit must not exceed dimensions of 13x22x14 inches or require additional operating clearance for a lid or drawer. The equipment must integrate with existing laboratory software and experimental workflows, specifically ensuring continuity with CFX Maestro software for data analysis and gene study features.
This acquisition is a combined synopsis/solicitation for commercial items conducted under the procedures of FAR Part 12 and FAR Part 13. The procurement is classified under NAICS 325414 for Biological Product (except Diagnostic) Manufacturing and PSC 6640 for Laboratory Equipment and Supplies. There is no set-aside assigned to this unrestricted solicitation. The government intends to award a firm-fixed-price contract based on a best-value determination considering technical capability, past performance, and cost, with non-price factors being significantly more important than cost or price.
Responses to this solicitation are due by 10:00 a.m. Eastern Daylight Time on May 22, 2026. While the metadata indicates California as the performance location, the description specifies the place of performance as Bethesda, Maryland. Towanda Daniels serves as the primary point of contact and purchasing agent for this requirement. The solicitation incorporates provisions and clauses through Federal Acquisition Circular (FAC) 2026-01. Offerors must include completed representations and certifications as part of their submission.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.